GB1340407A - Phenylethanolamine derivatives - Google Patents

Phenylethanolamine derivatives

Info

Publication number
GB1340407A
GB1340407A GB2245571A GB2245571A GB1340407A GB 1340407 A GB1340407 A GB 1340407A GB 2245571 A GB2245571 A GB 2245571A GB 2245571 A GB2245571 A GB 2245571A GB 1340407 A GB1340407 A GB 1340407A
Authority
GB
United Kingdom
Prior art keywords
formula
alkyl
compound
group
protecting group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2245571A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CH Boehringer Sohn AG and Co KG
Boehringer Ingelheim GmbH
Original Assignee
CH Boehringer Sohn AG and Co KG
Boehringer Ingelheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CH Boehringer Sohn AG and Co KG, Boehringer Ingelheim GmbH filed Critical CH Boehringer Sohn AG and Co KG
Publication of GB1340407A publication Critical patent/GB1340407A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/56Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups
    • C07C215/58Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups with hydroxy groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
    • C07C215/62Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups with hydroxy groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain the chain having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/48Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/64Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms
    • C07C217/66Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms with singly-bound oxygen atoms and six-membered aromatic rings bound to the same carbon atom of the carbon chain
    • C07C217/72Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms with singly-bound oxygen atoms and six-membered aromatic rings bound to the same carbon atom of the carbon chain linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

1340407 Phenylethanolamine derivatives BOEHRINGER INGELHEIM GmbH 19 April 1971 [25 Feb 1970] 22455/71 Heading C2C Compounds of the general formula (A = phenyl or substituted phenyl group, or condensed bicyclic group wherein the ring not directly bonded to the chain is carbocyclic or heterocyclic and saturated or aromatic; R 1 = H, alkyl, alkoxy; R 2 = H, Me, Et; R 3 = H, Me; R 4 = H, alkyl; R 5 = H, OH) and their salts are prepared by (a) removing the protecting group(s) in a compound of the formula (R 6,7 = H, protecting group (not both H)) or (b) reducing a compound of the formula (B = CO, CHOH), optionally followed in either case by isomer separation and/or salt formation. The preparation of starting materials for processes (a) and (b) by standard methods is described. The above compounds are of interest in the treatment of cardiac insufficiency and for stabilizing the circulation. They may be administered in the form of pharmaceutical preparations containing them in association with a carrier.
GB2245571A 1970-02-25 1971-04-19 Phenylethanolamine derivatives Expired GB1340407A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19702008654 DE2008654A1 (en) 1970-02-25 1970-02-25 Ammoathanoldenvate

Publications (1)

Publication Number Publication Date
GB1340407A true GB1340407A (en) 1973-12-12

Family

ID=5763256

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2245571A Expired GB1340407A (en) 1970-02-25 1971-04-19 Phenylethanolamine derivatives

Country Status (18)

Country Link
AT (3) AT305250B (en)
BE (1) BE763408A (en)
BG (3) BG18856A3 (en)
CH (4) CH568269A5 (en)
CS (3) CS166748B2 (en)
DE (1) DE2008654A1 (en)
ES (3) ES388561A1 (en)
FR (1) FR2081541B1 (en)
GB (1) GB1340407A (en)
IE (1) IE34970B1 (en)
IL (1) IL36269A (en)
NL (1) NL7102432A (en)
NO (1) NO131983C (en)
PL (3) PL82843B1 (en)
RO (3) RO60182A (en)
SE (1) SE377561B (en)
SU (2) SU421181A3 (en)
ZA (1) ZA711204B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA791403B (en) * 1978-04-10 1980-05-28 Draco Ab Composition of matter
FI70205C (en) * 1978-05-17 1986-09-15 Degussa FOERFARANDE FOER FRAMSTAELLNING AV NYA TERAPEUTISKT ANVAENDBARA L- / 3-HYDROXI-3-PHENYLPROPYL- (2) / - / 3-OXO-PROPYL / AMINER
US4853381A (en) * 1984-04-17 1989-08-01 Glaxo Group Limited Ethanolamine compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE630296A (en) * 1962-03-31

Also Published As

Publication number Publication date
PL84395B1 (en) 1976-03-31
NO131983C (en) 1975-09-03
IL36269A0 (en) 1971-04-28
BG19130A3 (en) 1975-04-30
BE763408A (en) 1971-08-24
CH568268A5 (en) 1975-10-31
RO60182A (en) 1976-08-15
NL7102432A (en) 1971-08-27
ES396175A1 (en) 1974-04-01
RO58559A (en) 1975-09-15
AT306706B (en) 1973-04-25
DE2008654A1 (en) 1971-09-09
FR2081541B1 (en) 1975-01-17
IE34970L (en) 1971-08-25
IL36269A (en) 1974-01-14
CS166748B2 (en) 1976-03-29
CH568270A5 (en) 1975-10-31
RO62244A (en) 1977-08-15
CS166749B2 (en) 1976-03-29
PL82843B1 (en) 1975-10-31
BG18856A3 (en) 1975-03-20
SE377561B (en) 1975-07-14
CH568269A5 (en) 1975-10-31
SU404229A3 (en) 1973-10-26
IE34970B1 (en) 1975-10-01
ES396174A1 (en) 1974-04-01
ZA711204B (en) 1972-10-25
SU421181A3 (en) 1974-03-25
BG18855A3 (en) 1975-03-20
AT305250B (en) 1973-02-12
CS166750B2 (en) 1976-03-29
FR2081541A1 (en) 1971-12-03
ES388561A1 (en) 1973-05-16
CH568271A5 (en) 1975-10-31
AT306707B (en) 1973-04-25
PL84268B1 (en) 1976-03-31
NO131983B (en) 1975-05-26
SU424349A3 (en) 1974-04-15

Similar Documents

Publication Publication Date Title
IE36947B1 (en) New esters their production and their medicinal use
GB1418822A (en) Imidazo-and pyrimido-2,1-b-quinazolin-2-ones and a process for the preparation thereof
GB1335261A (en) Isoquinoline derivatives
GB1147379A (en) 4-alkyl-dialkoxy-ª‡-methylphenethylamines and pharmacologically acceptable salts
GB1268951A (en) Phenoxy-amines
GB1340407A (en) Phenylethanolamine derivatives
GB1443692A (en) 1,2-diphenylethanolamine derivatives and their salts and the preparation thereof
GB1341955A (en) Aryl 4-piperidyl ketone derivatives
GB1227480A (en)
GB1363658A (en) Benzobicycloalkane compounds
GB1462095A (en) Substituted triazolo-1,5-benzodiazepines
GB1399470A (en) Derivatives of pyrazolopyridine ketones
ES376688A1 (en) Benzdiazepine derivatives
GB1345214A (en) Isoxazoles
IE34590L (en) Phenylethanolamine derivatives
GB1468079A (en) Ethanolamine derivatives
GB1312205A (en) Method and composition for lowering blood pressure
GB1208231A (en) beta-PHENETHYLAMINE DERIVATIVES AND A PROCESS FOR THE MANUFACTURE THEREOF
GB1184826A (en) Substituted Aryloxy Hydroxy Amines
GB1395772A (en) 1-aryl-3h-1,4-benzodiazepin-2,5-1h,4h-diones
GB1169990A (en) Phenoxy Propan-2-Olamines
GB1391081A (en) Optically active benzodiazepines
GB1398564A (en) 1-amino substituted-1-cycloalkane derivatives of 6-amino penicillanic acid
GB1338480A (en) Amines and process for their preparation
GB1219254A (en) Sydnonimine derivatives

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee